Powder: -20°C for 3 years | In solvent: -80°C for 1 year
U18666A is a cell-permeable drug and is a cholesterol synthesis and transport inhibitor. It inhibits replication of Ebola virus, dengue virus, and human hepatitis C virus.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 39.00 | |
5 mg | In stock | $ 64.00 | |
10 mg | In stock | $ 98.00 | |
25 mg | In stock | $ 195.00 | |
50 mg | In stock | $ 339.00 | |
100 mg | In stock | $ 538.00 | |
200 mg | In stock | $ 768.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 70.00 |
Description | U18666A is a cell-permeable drug and is a cholesterol synthesis and transport inhibitor. It inhibits replication of Ebola virus, dengue virus, and human hepatitis C virus. |
In vitro | U18666A, the antiviral effect is found to result from retarded viral trafficking in the cholesterol-loaded late endosomes/lysosomes and suppressed de novo sterol biosynthesis in treated infected cells. It is also observed an additive antiviral effect of U18666A with C75, a fatty acid synthase inhibitor [1][2]. |
Molecular Weight | 424.06 |
Formula | C25H42ClNO2 |
CAS No. | 3039-71-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (117.91 mM), sonification is recommended.
H2O: 10 mg/mL (23.58 mM), sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
U18666A 3039-71-2 Microbiology/Virology Others Proteases/Proteasome HCV Protease inhibit U-18666A Inhibitor Hepatitis C virus HCV inhibitor